Medicine compound for treating obese hypertensives and preparation method thereof
A technology for obesity-type hypertension and a composition is applied in the field of pharmaceutical compositions for treating obese-type hypertension patients and the field of preparation thereof, and achieves the effect of significant curative effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0015] In parts by weight, 50 parts of alprenol and 100 parts of orlistat are prepared into alprenol sustained-release pellets and orlistat sustained-release pellets with clinically acceptable auxiliary materials, and then mixed Made into capsules to obtain pharmaceutical composition capsules.
Embodiment 2
[0017] In parts by weight, 70 parts of alprenol and 100 parts of orlistat are prepared into alprenol sustained-release pellets and orlistat sustained-release pellets with clinically acceptable auxiliary materials, and then mixed Made into capsules to obtain pharmaceutical composition capsules.
Embodiment 3
[0019] In terms of parts by weight, 50 parts of metyrolol and 100 parts of orlistat were taken, and clinically acceptable auxiliary materials were used to prepare metyrolol sustained-release pellets and orlistat sustained-release pellets respectively, and then mixed to prepare Form into capsules to obtain pharmaceutical composition capsules.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
